logo
  

DineEquity Boosts Dividend, Stock Buyback Authorization

DineEquity, Inc. (DIN), the parent company of Applebee's Neighborhood Grill & Bar and IHOP restaurants, said Tuesday that its Board of Directors has approved 17% increase in the company's quarterly cash dividend to $0.875 per share.

The fourth quarter dividend will be payable on January 9, 2015 to the company's shareholders of record on December 3, 2014.

The company also said its board has approved an increase in the share repurchase authorization for the company's common stock, effective immediately, to $100 million from the remaining previous authorization of about $40 million.

The company anticipates using the majority of its remaining free cash flow after dividend payments for share repurchases.

"Given the substantial interest savings that will result from the securitization transaction, the time is right to announce our new capital allocation strategy. Our 99% franchised business model continues to generate strong and stable free cash flow. The meaningful increase in our quarterly cash dividend underscores our confidence in the future of our business," said Julia Stewart, Chairman and Chief Executive Officer of DineEquity.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
RELATED NEWS
Follow RTT